nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A bug in the resistance to EGFR inhibitors: is there a role for Mycoplasma and cytidine deaminase in reducing the activity of osimertinib in lung cancer patients?
|
Leonetti, Alessandro |
|
|
147 |
10 |
p. 3135-3137 |
artikel |
2 |
Anticancer activity of Helicobacter pylori ribosomal protein (HPRP) with iRGD in treatment of colon cancer
|
Yaghoubi, Atieh |
|
|
147 |
10 |
p. 2851-2865 |
artikel |
3 |
Application of four nutritional risk indexes in perioperative management for esophageal cancer patients
|
Wang, Pei-yu |
|
|
147 |
10 |
p. 3099-3111 |
artikel |
4 |
Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network
|
Schäfer, Vivien |
|
|
147 |
10 |
p. 3081-3089 |
artikel |
5 |
Association of tumor downstaging after neoadjuvant chemotherapy with survival in patients with locally advanced nasopharyngeal carcinoma: a retrospective cohort study
|
Wang, Weifeng |
|
|
147 |
10 |
p. 2913-2922 |
artikel |
6 |
Associations of circulating mediators of inflammation, cell regulation and immune response with esophageal squamous cell carcinoma
|
Camargo, M. Constanza |
|
|
147 |
10 |
p. 2885-2892 |
artikel |
7 |
Claudins as biomarkers of differential diagnosis and prognosis of tumors
|
Popova, Olga P. |
|
|
147 |
10 |
p. 2803-2817 |
artikel |
8 |
Clinical efficacy and safety of oral and intravenous vitamin C use in patients with malignant diseases
|
Hoppe, Catalina |
|
|
147 |
10 |
p. 3025-3042 |
artikel |
9 |
Clinical feasibility and oncologic safety of primary endoscopic submucosal dissection for clinical submucosal invasive early gastric cancer
|
Na, Ji Eun |
|
|
147 |
10 |
p. 3051-3061 |
artikel |
10 |
Correction to: Stereotactic body radiotherapy for elderly patients (≥ 75 years) with early‑stage non‑small cell lung cancer
|
Shu, Zekai |
|
|
147 |
10 |
p. 3139 |
artikel |
11 |
Differential expression of stem cell markers in proliferating cells in glioma
|
Rehfeld, Marten |
|
|
147 |
10 |
p. 2969-2982 |
artikel |
12 |
Efficacy of three BCG strains (Connaught, TICE and RIVM) with or without secondary resection (re-TUR) for intermediate/high-risk non-muscle-invasive bladder cancers: results from a retrospective single-institution cohort analysis
|
Del Giudice, Francesco |
|
|
147 |
10 |
p. 3073-3080 |
artikel |
13 |
Epidemiology and prognosis of parathyroid carcinoma: real-world data using nationwide cohort
|
Kong, Sung Hye |
|
|
147 |
10 |
p. 3091-3097 |
artikel |
14 |
Germline and tumor BRCA1/2 pathogenic variants in Chinese triple-negative breast carcinomas
|
Ji, Gang |
|
|
147 |
10 |
p. 2935-2944 |
artikel |
15 |
HER2-PI9 and HER2-I12: two novel and functionally active splice variants of the oncogene HER2 in breast cancer
|
Hart, Vic |
|
|
147 |
10 |
p. 2893-2912 |
artikel |
16 |
Human papillomavirus (HPV) types 16 and 18 infection and esophageal squamous cell carcinoma: a systematic review and meta-analysis
|
Petrelli, Fausto |
|
|
147 |
10 |
p. 3011-3023 |
artikel |
17 |
Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-181a retards nasopharyngeal carcinoma development by mediating KDM5C
|
Liu, Jin |
|
|
147 |
10 |
p. 2867-2877 |
artikel |
18 |
Increased lysophosphatidylcholine acyltransferase 1 expression is unrelated to prognosis of esophageal cancer patients
|
Bellon, Eugen |
|
|
147 |
10 |
p. 2879-2884 |
artikel |
19 |
Inhibitors of PD-1/PD-L1 and ERK1/2 impede the proliferation of receptor positive and triple-negative breast cancer cell lines
|
Bräutigam, Karen |
|
|
147 |
10 |
p. 2923-2933 |
artikel |
20 |
Microsatellite instability (MSI-H) is associated with a high immunoscore but not with PD-L1 expression or increased survival in patients (pts.) with metastatic colorectal cancer (mCRC) treated with oxaliplatin (ox) and fluoropyrimidine (FP) with and without bevacizumab (bev): a pooled analysis of the AIO KRK 0207 and RO91 trials
|
Noepel-Duennebacke, Stefanie |
|
|
147 |
10 |
p. 3063-3072 |
artikel |
21 |
Performance of international prognostic indices in plasmablastic lymphoma: a comparative evaluation
|
Hertel, Nadine |
|
|
147 |
10 |
p. 3043-3050 |
artikel |
22 |
Prognostic value and characterization of NTRK1 variation by fluorescence in situ hybridization in esophageal squamous cell carcinoma
|
Yu, Zixiang |
|
|
147 |
10 |
p. 3113-3121 |
artikel |
23 |
Relationship between lung function and lung cancer risk: a pooled analysis of cohorts plus Mendelian randomization study
|
Su, Zixuan |
|
|
147 |
10 |
p. 2837-2849 |
artikel |
24 |
Retrospective analysis of cancer-specific gene expression panel for thyroid fine needle aspiration specimens
|
Wang, Yongchun |
|
|
147 |
10 |
p. 2983-2991 |
artikel |
25 |
The advanced development of Cx43 and GAP-43 mediated intercellular networking in IDH1 wildtype diffuse and anaplastic gliomas with lower mitotic rate
|
Krigers, Aleksandrs |
|
|
147 |
10 |
p. 3003-3009 |
artikel |
26 |
The role of metformin on lung cancer survival: the first systematic review and meta-analysis of observational studies and randomized clinical trials
|
Brancher, Suzan |
|
|
147 |
10 |
p. 2819-2836 |
artikel |
27 |
Treatment efficacy and safety of regorafenib plus drug-eluting beads-transarterial chemoembolization versus regorafenib monotherapy in colorectal cancer liver metastasis patients who fail standard treatment regimens
|
Cao, Fei |
|
|
147 |
10 |
p. 2993-3002 |
artikel |
28 |
Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma
|
Han, Sojung |
|
|
147 |
10 |
p. 3123-3133 |
artikel |
29 |
Treatment of breast and colon cancer cell lines with anti-helmintic benzimidazoles mebendazole or albendazole results in selective apoptotic cell death
|
Petersen, Jakeb S. S. M. |
|
|
147 |
10 |
p. 2945-2953 |
artikel |
30 |
Upregulation of the ErbB family by EZH2 in hepatocellular carcinoma confers resistance to FGFR inhibitor
|
Prawira, Aldo |
|
|
147 |
10 |
p. 2955-2968 |
artikel |